The comparative efficacy and safety of the angiotensin receptor blockers in the management of hypertension and other cardiovascular diseases.
about
High fat diet confers vascular hyper-contractility against angiotensin II through upregulation of MLCK and CPI-17Cost-benefit effectiveness of angiotensin-II receptor blockers in patients with uncomplicated hypertension: A comparative analysis.Pharmacotherapeutic Targeting of G Protein-Coupled Receptors in Oncology: Examples of Approved Therapies and Emerging Concepts.Azilsartan Medoxomil, an Angiotensin II Receptor Antagonist for the Treatment of Hypertension.The Pharmacogenomic and Metabolomic Predictors of ACE Inhibitor and Angiotensin II Receptor Blocker Effectiveness and Safety.Evaluation of the angiotensin II receptor blocker azilsartan medoxomil in African-American patients with hypertension.Antihypertensive treatment and blood pressure control in patients with hypertension in daily clinical practice: a cross-sectional, multicenter, observational study in Egypt.Divergent Spatiotemporal Interaction of Angiotensin Receptor Blocking Drugs with Angiotensin Type 1 Receptor.24-Hour blood pressure response to lower dose (30 mg) fimasartan in Korean patients with mild to moderate essential hypertension.Computational design of Phe-Tyr dipeptide and preparation, characterization, cytotoxicity studies of Phe-Tyr dipeptide loaded PLGA nanoparticles for the treatment of hypertension.Inhibitory Effects of Angiotensin II Receptor Blockade on Human Tenon Fibroblast Migration and Reactive Oxygen Species Production in Cell Culture.
P2860
Q28359726-7EDB51A2-49F0-4381-B94F-2AF8B3F2C3F7Q38834278-ED54CF2F-7E91-4DB1-94BA-A212FB0B0D53Q39236911-7E99B91C-A3C7-44E0-BC32-A8552859E27EQ39264079-AAB7864F-487E-476B-AC3C-5A96CA38BDE6Q39456476-85CE3E5B-A69B-45FD-B4F0-A29E0360E708Q45058875-76C108E5-9E4C-4124-A26A-792905187044Q46807861-4D56D957-D85E-4CF4-9C91-ED2ABA731E66Q47383912-68371C7D-BA97-45A9-A627-C7E968414D60Q47430437-DAF44EF9-0339-4574-87E6-BC27E9E56021Q47761665-B6326209-CF0B-417C-B897-07CAC94C9BB9Q52587068-0BBB47FE-CC0A-40D2-92A3-9BA11A6CA446
P2860
The comparative efficacy and safety of the angiotensin receptor blockers in the management of hypertension and other cardiovascular diseases.
description
2015 nî lūn-bûn
@nan
2015 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
The comparative efficacy and s ...... other cardiovascular diseases.
@ast
The comparative efficacy and s ...... other cardiovascular diseases.
@en
type
label
The comparative efficacy and s ...... other cardiovascular diseases.
@ast
The comparative efficacy and s ...... other cardiovascular diseases.
@en
prefLabel
The comparative efficacy and s ...... other cardiovascular diseases.
@ast
The comparative efficacy and s ...... other cardiovascular diseases.
@en
P2093
P2860
P1433
P1476
The comparative efficacy and s ...... other cardiovascular diseases.
@en
P2093
C Michael White
Hazel Mae A Abraham
William B White
P2860
P2888
P356
10.1007/S40264-014-0239-7
P577
2015-01-01T00:00:00Z